These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 31091067)
1. The Effect of Vitamin D Supplementation on Insulin Resistance among Women with Polycystic Ovary Syndrome. Salehpour S; Hosseini S; Nazari L; Hosseini M; Saharkhiz N JBRA Assist Reprod; 2019 Aug; 23(3):235-238. PubMed ID: 31091067 [TBL] [Abstract][Full Text] [Related]
2. Vitamin D supplementation has no effect on insulin resistance assessment in women with polycystic ovary syndrome and vitamin D deficiency. Ardabili HR; Gargari BP; Farzadi L Nutr Res; 2012 Mar; 32(3):195-201. PubMed ID: 22464806 [TBL] [Abstract][Full Text] [Related]
3. The effect of vitamin D supplementation on insulin resistance, visceral fat and adiponectin in vitamin D deficient women with polycystic ovary syndrome: a randomized placebo-controlled trial. Seyyed Abootorabi M; Ayremlou P; Behroozi-Lak T; Nourisaeidlou S Gynecol Endocrinol; 2018 Jun; 34(6):489-494. PubMed ID: 29271278 [TBL] [Abstract][Full Text] [Related]
4. Calcium plus vitamin D supplementation affects glucose metabolism and lipid concentrations in overweight and obese vitamin D deficient women with polycystic ovary syndrome. Asemi Z; Foroozanfard F; Hashemi T; Bahmani F; Jamilian M; Esmaillzadeh A Clin Nutr; 2015 Aug; 34(4):586-92. PubMed ID: 25300649 [TBL] [Abstract][Full Text] [Related]
5. Effects of vitamin D supplementation in women with polycystic ovary syndrome: a review. Menichini D; Facchinetti F Gynecol Endocrinol; 2020 Jan; 36(1):1-5. PubMed ID: 31187648 [TBL] [Abstract][Full Text] [Related]
6. The effects of vitamin D supplementation on metabolic profiles and gene expression of insulin and lipid metabolism in infertile polycystic ovary syndrome candidates for in vitro fertilization. Dastorani M; Aghadavod E; Mirhosseini N; Foroozanfard F; Zadeh Modarres S; Amiri Siavashani M; Asemi Z Reprod Biol Endocrinol; 2018 Oct; 16(1):94. PubMed ID: 30286768 [TBL] [Abstract][Full Text] [Related]
7. A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome. Javed Z; Papageorgiou M; Deshmukh H; Kilpatrick ES; Mann V; Corless L; Abouda G; Rigby AS; Atkin SL; Sathyapalan T Nutrients; 2019 Jan; 11(1):. PubMed ID: 30658483 [TBL] [Abstract][Full Text] [Related]
8. Association of hypovitaminosis D with metabolic disturbances in polycystic ovary syndrome. Wehr E; Pilz S; Schweighofer N; Giuliani A; Kopera D; Pieber TR; Obermayer-Pietsch B Eur J Endocrinol; 2009 Oct; 161(4):575-82. PubMed ID: 19628650 [TBL] [Abstract][Full Text] [Related]
9. High-dose vitamin D supplementation and measures of insulin sensitivity in polycystic ovary syndrome: a randomized, controlled pilot trial. Raja-Khan N; Shah J; Stetter CM; Lott ME; Kunselman AR; Dodson WC; Legro RS Fertil Steril; 2014 Jun; 101(6):1740-6. PubMed ID: 24636395 [TBL] [Abstract][Full Text] [Related]
10. The Effects of Vitamin D on Metabolic Profiles in Women with Polycystic Ovary Syndrome: A Systematic Review. Williams A; Babu JR; Wadsworth DD; Burnett D; Geetha T Horm Metab Res; 2020 Jul; 52(7):485-491. PubMed ID: 32422661 [TBL] [Abstract][Full Text] [Related]
11. Effects of vitamin D supplementation on metabolic parameters in women with polycystic ovary syndrome: a randomized controlled trial. Wen X; Wang L; Li F; Yu X J Ovarian Res; 2024 Jul; 17(1):147. PubMed ID: 39014475 [TBL] [Abstract][Full Text] [Related]
12. Effects of vitamin D supplementation on insulin sensitivity and androgen levels in vitamin-D-deficient polycystic ovary syndrome patients. Karadağ C; Yoldemir T; Yavuz DG J Obstet Gynaecol Res; 2018 Feb; 44(2):270-277. PubMed ID: 29094433 [TBL] [Abstract][Full Text] [Related]
13. Effect of high-dose vitamin D supplementation in combination with weight loss diet on glucose homeostasis, insulin resistance, and matrix metalloproteinases in obese subjects with vitamin D deficiency: a double-blind, placebo-controlled, randomized clinical trial. Aliashrafi S; Ebrahimi-Mameghani M; Jafarabadi MA; Lotfi-Dizaji L; Vaghef-Mehrabany E; Arefhosseini SR Appl Physiol Nutr Metab; 2020 Oct; 45(10):1092-1098. PubMed ID: 31874050 [TBL] [Abstract][Full Text] [Related]
14. The effect of vitamin D replacement therapy on insulin resistance and androgen levels in women with polycystic ovary syndrome. Selimoglu H; Duran C; Kiyici S; Ersoy C; Guclu M; Ozkaya G; Tuncel E; Erturk E; Imamoglu S J Endocrinol Invest; 2010 Apr; 33(4):234-8. PubMed ID: 19820295 [TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin D supplementation on metabolic and endocrine parameters in PCOS: a randomized-controlled trial. Trummer C; Schwetz V; Kollmann M; Wölfler M; Münzker J; Pieber TR; Pilz S; Heijboer AC; Obermayer-Pietsch B; Lerchbaum E Eur J Nutr; 2019 Aug; 58(5):2019-2028. PubMed ID: 29946756 [TBL] [Abstract][Full Text] [Related]
16. Effect of Two Different Doses of Vitamin D Supplementation on Metabolic Profiles of Insulin-Resistant Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Foroozanfard F; Talebi M; Samimi M; Mehrabi S; Badehnoosh B; Jamilian M; Maktabi M; Asemi Z Horm Metab Res; 2017 Aug; 49(8):612-617. PubMed ID: 28679142 [TBL] [Abstract][Full Text] [Related]
17. The Effects of Vitamin D Supplementation on Metabolic Status of Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Maktabi M; Chamani M; Asemi Z Horm Metab Res; 2017 Jul; 49(7):493-498. PubMed ID: 28679140 [TBL] [Abstract][Full Text] [Related]
18. Effects of synbiotic supplementation on metabolic parameters and apelin in women with polycystic ovary syndrome: a randomised double-blind placebo-controlled trial. Karimi E; Moini A; Yaseri M; Shirzad N; Sepidarkish M; Hossein-Boroujerdi M; Hosseinzadeh-Attar MJ Br J Nutr; 2018 Feb; 119(4):398-406. PubMed ID: 29498342 [TBL] [Abstract][Full Text] [Related]
19. Benefits of using a microencapsulated vitamin D delivery system in women with polycystic ovary syndrome. Yanachkova V; Staynova R; Stoev S; Naseva E Eur J Hosp Pharm; 2023 Sep; 30(5):284-287. PubMed ID: 34853015 [TBL] [Abstract][Full Text] [Related]
20. Hormonal and Metabolic Effects of Coenzyme Q10 and/or Vitamin E in Patients With Polycystic Ovary Syndrome. Izadi A; Ebrahimi S; Shirazi S; Taghizadeh S; Parizad M; Farzadi L; Gargari BP J Clin Endocrinol Metab; 2019 Feb; 104(2):319-327. PubMed ID: 30202998 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]